학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 694건 | 목록 1~20
Academic Journal
Koutroumpakis E; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1451, Houston, TX, 77030, USA. EKoutroumpakis@mdanderson.org.; Patel R; Department of Medicine, Lahey Hospital & Medical Center, Burlington, MA, USA.; Khadke S; Division of Cardiovascular Medicine, Department of Medicine, Lahey Hospital & Medical Center, 41 Mall Road, Burlington, MA, 01805, USA.; Bedrosian A; Department of Medicine, Lahey Hospital & Medical Center, Burlington, MA, USA.; Kumar A; Department of Medicine, Cleveland Clinic, Akron General, Akron, OH, USA.; Kong Y; Division of Cardiovascular Medicine, Department of Medicine, Lahey Hospital & Medical Center, 41 Mall Road, Burlington, MA, 01805, USA.; Connell B; Division of Oncology, Department of Medicine, Lahey Hospital & Medical Center, Burlington, MA, USA.; Upadhyay J; Division of Endocrinology, Department of Medicine, Lahey Hospital & Medical Center, Burlington, MA, USA.; Dani SS; Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, USA.; Hahn AW; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Logothetis CJ; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Al-Kindi S; Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, USA.; Butler J; Baylor Scott and White Research Institute, Dallas, TX, USA.; University of Mississippi, Jackson, MS, USA.; Nohria A; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Ganatra S; Division of Cardiovascular Medicine, Department of Medicine, Lahey Hospital & Medical Center, 41 Mall Road, Burlington, MA, 01805, USA. Sarju.Ganatra@Lahey.Org.; Deswal A; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1451, Houston, TX, 77030, USA. ADeswal@mdanderson.org.
Publisher: Kluwer Academic For The International Society For Cardiovascular Pharmacotherapy Country of Publication: United States NLM ID: 8712220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7241 (Electronic) Linking ISSN: 09203206 NLM ISO Abbreviation: Cardiovasc Drugs Ther Subsets: MEDLINE
Editorial & Opinion
Logothetis CJ; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: clogothe@mdanderson.org.; Hahn AW; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE
Academic Journal
Gillessen, SilkeBossi, AlbertoDavis, Ian D.de Bono, JohannFizazi, KarimJames, Nicholas D.Mottet, NicolasShore, NealSmall, EricSmith, MatthewSweeney, Christopher J.Tombal, BertrandAntonarakis, Emmanuel S.Aparicio, Ana M.Armstrong, Andrew J.Attard, GerhardtBeer, Tomasz M.Beltran, HimishaBjartell, AndersBlanchard, PierreBriganti, AlbertoBristow, Rob G.Bulbul, MuhammadCaffo, OrazioCastellano, DanielCastro, ElenaCheng, Heather H.Chi, Kim N.Chowdhury, SimonClarke, Caroline S.Clarke, NoelDaugaard, GedskeDe Santis, MariaDuran, IgnacioEeles, RossEfstathiou, EleniEfstathiou, JasonEkeke, Onyeanunam NgoziEvans, Christopher P.Fanti, StefanoFeng, Felix Y.Fonteyne, ValerieFossati, NicolaFrydenberg, MarkGeorge, DanGleave, MartinGravis, GwenaelleHalabi, SusanHeinrich, DanielHerrmann, KenHigano, CelestiaHofman, Michael S.Horvath, Lisa G.Hussain, MahaJereczek-Fossa, Barbara A.Jones, RobKanesvaran, RavindranKellokumpu-Lehtinen, Pirkko-LiisaKhauli, Raja B.Klotz, LaurenceKramer, GeroLeibowitz, RajaLogothetis, ChristopherMahal, BrandonMaluf, FernandoMateo, JoaquinMatheson, DavidMehra, NivenMerseburger, AxelMorgans, Alicia K.Morris, Michael J.Mrabti, HindMukherji, DeborahMurphy, Declan G.Murthy, VedangNguyen, Paul L.Oh, William K.Ost, PietO’Sullivan, Joe M.Padhani, Anwar R.Pezaro, Carmel J.Poon, Darren M.C.Pritchard, Colin C.Rabah, Danny M.Rathkopf, DanaReiter, Robert E.Rubin, Mark A.Ryan, Charles J.Saad, FredSade, Juan PabloSartor, OliverScher, Howard I.Sharifi, NimaSkoneczna, IwonaSoule, HowardSpratt, Daniel E.Srinivas, SandySternberg, Cora N.Steuber, ThomasSuzuki, HiroyoshiSydes, Matthew R.Taplin, Mary-EllenTilki, DeryaTürkeri, LeventTurco, FabioUemura, HirojiUemura, HirotsuguÜrün, YükselVale, Claire L.van Oort, IngeVapiwala, NehaWalz, JochenYamoah, KosjYe, DingweiYu, Evan Y.Zapatero, AlmudenaZilli, ThomasOmlin, Aurelius
In European Journal of Cancer May 2023 185:178-215
Academic Journal
Beltran H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Calais J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, CA, United States.; Emmett L; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital Sydney, St Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia.; Kuo PH; Department of Radiology, City of Hope National Medical Center, Duarte, CA, United States.; Logothetis CJ; Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX, United States.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Academic Journal
Koutroumpakis E; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.; Venkatesh N; Department of Medicine, Baylor College of Medicine, Houston, TX 77030, United States.; Aparicio A; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.; Song J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 770304, United States.; Panaretakis T; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.; Deswal A; Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.; Logothetis CJ; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.; Frigo DE; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.; Department of Cancer Systems Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.; Hahn AW; Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Academic Journal
Mak CSL; Department of Genitourinary Medical Oncology, USA.; Zhu M; Department of Genitourinary Medical Oncology, USA.; Fu J; Department of Genitourinary Medical Oncology, USA.; Liang X; Department of Genitourinary Medical Oncology, USA.; Wang X; Department of Genitourinary Medical Oncology, USA.; Yuan F; Pathology, Pharmacology and Chemical Biology, Center for Drug Discovery, Baylor College of Medicine, USA.; Wang F; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hoang AG; Department of Genitourinary Medical Oncology, USA.; Song X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Shepherd P; Department of Genitourinary Medical Oncology, USA.; Liang D; Department of Genitourinary Medical Oncology, USA.; Suh J; Department of Genitourinary Medical Oncology, USA.; Contreras J; Department of Genitourinary Medical Oncology, USA.; Dang T; Department of Genitourinary Medical Oncology, USA.; Yan C; Department of Genitourinary Medical Oncology, USA.; Figueroa B; Department of Genitourinary Medical Oncology, USA.; Mazzocco M; Department of Genitourinary Medical Oncology, USA.; Luo A; Department of Genitourinary Medical Oncology, USA.; Pradhan B; Department of Genitourinary Medical Oncology, USA.; Park J; Department of Genitourinary Medical Oncology, USA.; Bashir M; Department of Cancer Systems Imaging, USA.; Zhang M; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Metzger E; Klinik für Urologie und Zentrale Klinische Forschung, Klinikum der Albert-Ludwigs-Universität Freiburg, Germany.; Schüle R; Klinik für Urologie und Zentrale Klinische Forschung, Klinikum der Albert-Ludwigs-Universität Freiburg, Germany.; Jain AK; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Karasik E; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Frigo D; Department of Cancer Systems Imaging, USA.; Foster BA; Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Lee MG; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Corn P; Department of Genitourinary Medical Oncology, USA.; Logothetis CJ; Department of Genitourinary Medical Oncology, USA.; Aparicio A; Department of Genitourinary Medical Oncology, USA.; Navone N; Department of Genitourinary Medical Oncology, USA.; Troncoso P; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tan Z; Pathology, Pharmacology and Chemical Biology, Center for Drug Discovery, Baylor College of Medicine, USA.; Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lin SH; Department of Genitourinary Medical Oncology, USA; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang G; Department of Genitourinary Medical Oncology, USA; The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX, USA. Electronic address: gwang6@mdanderson.org.
Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE
Academic Journal
Corn PG; Departments of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA.; Yu G; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA.; Fan Y; Departments of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA.; Zhang M; Departments of Pathology, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA.; Troncoso P; Departments of Pathology, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA.; Surasi DS; Departments of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA.; Liu S; Departments of Biostatistics, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, 77030, Houston, TX, USA.; Ajani JA; Departments of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA.; Logothetis CJ; Departments of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA.; Wang G; Departments of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, 77030, Houston, TX, USA.; Panaretakis T; Departments of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA. tpanaretakis@mdanderson.org.; Lin SH; Departments of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA. slin@mdanderson.org.; Departments of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, 77030, Houston, TX, USA. slin@mdanderson.org.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, 77030, Houston, TX, USA. slin@mdanderson.org.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5608 (Electronic) Linking ISSN: 13657852 NLM ISO Abbreviation: Prostate Cancer Prostatic Dis Subsets: MEDLINE
Academic Journal
UKGPCS collaborators 2021, 'Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer', Prostate Cancer and Prostatic Diseases. https://doi.org/10.1038/s41391-020-00311-2
Karunamuni, R, Walsh, E I, Turner, E L, Lane, J A, Martin, R M, Donovan, J L, Seibert, T M & et al. 2021, 'Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer', Prostate Cancer & Prostatic Diseases, vol. 24, no. 2, pp. 532-541. https://doi.org/10.1038/s41391-020-00311-2
UKGPCS Collaborators, APCB BioResource (Australian Prostate Cancer BioResource), IMPACT Study Steering Committee and Collaborators, Canary PASS Investigators, Profile Study Steering Committee & PRACTICAL consortium 2021, ' Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer ', Prostate Cancer and Prostatic Diseases, vol. 24, no. 2, pp. 532-541 . https://doi.org/10.1038/s41391-020-00311-2
UKGPCS Collaborators 2021, 'Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer', Prostate Cancer and Prostatic Diseases. https://doi.org/10.1038/s41391-020-00311-2
Prostate Cancer and Prostatic Diseases, vol 24, iss 2
Karunamuni, R A, Huynh-Le, M-P, Fan, C C, Thompson, W, Eeles, R A, Kote-Jarai, Z, Muir, K, Lophatananon, A, Schleutker, J, Pashayan, N, Batra, J, Grönberg, H, Walsh, E I, Turner, E L, Lane, A, Martin, R M, Neal, D E, Donovan, J L, Hamdy, F C, Nordestgaard, B G, Tangen, C M, MacInnis, R J, Wolk, A, Albanes, D, Haiman, C A, Travis, R C, Stanford, J L, Mucci, L A, West, C M L, Nielsen, S F, Kibel, A S, Wiklund, F, Cussenot, O, Berndt, S I, Koutros, S, Sørensen, K D, Cybulski, C, Grindedal, E M, Park, J Y, Ingles, S A, Maier, C, Hamilton, R J, Rosenstein, B S, Vega, A, Kogevinas, M, Penney, K L, Teixeira, M R, Brenner, H, John, E M, Kaneva, R & UKGPCS collaborators 2021, 'Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer', Prostate Cancer and Prostatic Diseases, vol. 24, pp. 532-541. https://doi.org/10.1038/s41391-020-00311-2
Academic Journal
Venkatesh N; Department of Internal Medicine, Baylor College of Medicine, Houston, TX.; Chauhan PK; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Mukhida SS; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Division of Diagnostic Imaging, Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX.; Grewal K; Department of Internal Medicine, Baylor College of Medicine, Houston, TX.; Aparicio A; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Pilie PG; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Subudhi SK; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Corn PG; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Sachdeva A; Division of Cancer Sciences, Genitourinary Cancer Research Group, University of Manchester, Manchester, United Kingdom.; Department of Surgery, The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom.; Desai M; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Siddiqui BA; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Zurita AJ; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Pain D; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Gregg JR; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Frigo DE; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Division of Diagnostic Imaging, Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX.; Logothetis CJ; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Msaouel P; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Koutroumpakis E; Division of Internal Medicine, Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX.; Hahn AW; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE
Academic Journal
Hahn AW; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ahahn@mdanderson.org.; Tidwell RS; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pilie PG; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Yu Y; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Liu J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Surasi DS; Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Titus M; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Venkatesh N; Department of Internal Medicine, Baylor College of Medicine, Houston, TX, USA.; Panaretakis T; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gregg JR; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zurita AJ; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Siddiqui BA; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Corn PG; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Subudhi SK; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Msaouel P; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, USA.; Koutroumpakis E; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Huff CD; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Aparicio A; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; McQuade JL; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Frigo DE; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Logothetis CJ; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, USA.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5608 (Electronic) Linking ISSN: 13657852 NLM ISO Abbreviation: Prostate Cancer Prostatic Dis Subsets: MEDLINE
Academic Journal
Hahn AW; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Manyam GC; Division of Basic Sciences, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chapin BF; Division of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhang M; Division of Pathology and Laboratory Medicine, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Yu Y; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pettaway CA; Division of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chery L; Division of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pisters LL; Division of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ward JF; Division of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gregg JR; Division of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Papadopoulos J; Division of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kamat AM; Division of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lozano M; Division of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hoang A; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Broom B; Division of Basic Sciences, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Huff CD; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Logothetis CJ; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Troncoso P; Division of Pathology and Laboratory Medicine, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pilié PG; Division of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Davis JW; Division of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-410X (Electronic) Linking ISSN: 14644096 NLM ISO Abbreviation: BJU Int Subsets: MEDLINE
Academic Journal
Schumacher, FROlama, AABerndt, SIBenlloch, SAhmed, MSaunders, EJDadaev, TLeongamornlert, DAnokian, ECieza-Borrella, CGoh, CBrook, MNSheng, XFachal, LDennis, JTyrer, JMuir, KLophatananon, AStevens, VLGapstur, SMCarter, BDTangen, CMGoodman, PJThompson, IMBatra, JChambers, SMoya, LClements, JHorvath, LTilley, WRisbridger, GPGronberg, HAly, MNordström, TPharoah, PPashayan, NSchleutker, JTammela, TLJSipeky, CAuvinen, AAlbanes, DWeinstein, SWolk, AHåkansson, NWest, CMLDunning, AMBurnet, NMucci, LAGiovannucci, EAndriole, GLCussenot, OCancel-Tassin, GKoutros, SFreeman, LE BeaneSorensen, KDOrntoft, TFBorre, MMaehle, LGrindedal, EMNeal, DEDonovan, JLHamdy, FCMartin, RMTravis, RCKey, TJHamilton, RJFleshner, NEFinelli, AIngles, SAStern, MCRosenstein, BSKerns, SLOstrer, HLu, Y-JZhang, H-WFeng, NMao, XGuo, XWang, GSun, ZGiles, GGSouthey, MCMacinnis, RJFitzgerald, LMKibel, ASDrake, BFVega, AGómez-Caamaño, ASzulkin, REklund, MKogevinas, MLlorca, JCastaño-Vinyals, GPenney, KLStampfer, MPark, JYSellers, TALin, H-YStanford, JLCybulski, CWokolorczyk, DLubinski, JOstrander, EAGeybels, MSNordestgaard, BGNielsen, SFWeischer, MBisbjerg, RRøder, MAIversen, PBrenner, HCuk, KHolleczek, BMaier, CLuedeke, MSchnoeller, TKim, JLogothetis, CJJohn, EMTeixeira, MRPaulo, PCardoso, MNeuhausen, SLSteele, LDing, YCDe Ruyck, KDe Meerleer, GOst, PRazack, ALim, JTeo, S-HLin, DWNewcomb, LFLessel, DGamulin, MKulis, TKaneva, RUsmani, NSinghal, SSlavov, CMitev, VParliament, MClaessens, FJoniau, SVan Den Broeck, TLarkin, STownsend, PAAukim-Hastie, CGago-Dominguez, MCastelao, JEMartinez, MERoobol, MJJenster, GVan Schaik, RHNMenegaux, FTruong, TKoudou, YAXu, JKhaw, K-TCannon-Albright, LPandha, HMichael, AThibodeau, SNMcDonnell, SKSchaid, DJLindstrom, STurman, CMa, JHunter, DJRiboli, ESiddiq, ACanzian, FKolonel, LNLe Marchand, LHoover, RNMachiela, MJCui, ZKraft, PAmos, CIConti, DVEaston, DFWiklund, FChanock, SJHenderson, BEKote-Jarai, ZHaiman, CAEeles, RAStudy, ProfileBioresource, AStudy, ImpactInvestigators, Canary Pass(Bpc3), Breast And Prostate Cancer Cohort ConsortiumConsortium, Practical (Prostate Cancer Association Group To Investigate Cancer-Associated Alterations In The Genome)Sweden, C(Pegasus), Prostate Cancer Genome-Wide Association Study Of Uncommon Susceptibility LociConsortium, Genetic Associations And Mechanisms In Oncology (Game-On)/Elucidating Loci Involved In Prostate Cancer Susceptibility (Ellipse)
the Profile Study 2018, 'Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci', Nature Genetics, vol. 50, no. 7, 8, pp. 928-936. https://doi.org/10.1038/s41588-018-0142-8
Muir, K, Lophatananon, A, West, C, Townsend, P, Burnet, N & et al. 2018, 'Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.', Nat Genet, vol. 50, no. 7, pp. 928-936. https://doi.org/10.1038/s41588-018-0142-8
Nature Genetics, vol 50, iss 7
Schumacher, F R, Al Olama, A A, Berndt, S I, Benlloch, S, Ahmed, M, Saunders, E J, Dadaev, T, Leongamornlert, D, Anokian, E, Cieza-Borrella, C, Goh, C, Brook, M N, Sheng, X, Fachal, L, Dennis, J, Tyrer, J, Muir, K, Lophatananon, A, Stevens, V L, Gapstur, S M, Carter, B D, Tangen, C M, Goodman, P J, Thompson, I M, Batra, J, Chambers, S, Moya, L, Clements, J, Horvath, L, Tilley, W, Risbridger, G P, Gronberg, H, Aly, M, Nordström, T, Pharoah, P, Pashayan, N, Schleutker, J, Tammela, T L J, Sipeky, C, Auvinen, A, Albanes, D, Weinstein, S, Wolk, A, Sorensen, K D, Orntoft, T F, Borre, M & Profile Study 2018, 'Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci', Nature Genetics, vol. 50, no. 7, pp. 928-936. https://doi.org/10.1038/s41588-018-0142-8
검색 결과 제한하기
제한된 항목
[검색어] Logothetis CJ
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어